Study objectives: To assess the frequencies of three polymorphisms at amino
acid positions 16, 27, and 164 of the beta (2)-adrenoceptor (beta (2)-AR)
gene and their effects on COPD patients.
Design: Prospective, case-control study.
Patients: Sixty-five patients with COPD and 41 healthy subjects were includ
ed.
Measurements: Polymorphisms of the beta (2)-AR coding block were delineated
using an allele-specific polymerase chain reaction (PCR) approach. The all
ele-specific PCR technique was verified by direct dideoxy sequencing of PCR
products. Pulmonary function tests were performed in all patients.
Results: The Arg16 beta (2)-AR polymorphism was less prevalent in COPD pati
ents than in healthy populations (p=0.01). A significant correlation (p<0.0
18) between the Gln27 <beta>(2)-AR Poly morphism and FEV1 percent predicted
value was found. Patients with the Gln27 polymorphism had a higher percent
age of low FEV1 percent predicted than did patients with the GlnGlu and Glu
Glu variants.
Conclusions: The polymorphism of Gly16 may increase the patient's susceptib
ility to the development of COPD. The Gln27 beta (2)-AR polymorphism may be
associated with the severity of COPD in a Chinese population.